Activation of the Contact System at the Surface of Fusobacterium necrophorum Represents a Possible Virulence Mechanism in Lemièrre's Syndrome
暂无分享,去创建一个
L. Björck | I. Frick | M. Rasmussen | K. Holm | Karin Holm
[1] H. Herwald,et al. Adsorption of Components of the Plasma Kinin-Forming System on the Surface of Porphyromonas gingivalis Involves Gingipains as the Major Docking Platforms , 2010, Infection and Immunity.
[2] T. Renné,et al. A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo. , 2010, Blood.
[3] H. Herwald,et al. Contact system activation in severe infectious diseases , 2010, Journal of Molecular Medicine.
[4] T. Renné,et al. Platelet Polyphosphates Are Proinflammatory and Procoagulant Mediators In Vivo , 2009, Cell.
[5] L. Björck,et al. Treatment of invasive streptococcal infection with a peptide derived from human high-molecular weight kininogen. , 2009, Blood.
[6] J. Brazier,et al. lktA-encoded leukotoxin is not a universal virulence factor in invasive Fusobacterium necrophorum infections in animals and man. , 2009, Journal of medical microbiology.
[7] S. Meri,et al. Factor H Binding as a Complement Evasion Mechanism for an Anaerobic Pathogen, Fusobacterium necrophorum1 , 2008, The Journal of Immunology.
[8] Z. Shariat-Madar,et al. Identification of lipopolysaccharide binding site on high molecular weight kininogen. , 2008, Biochemical and biophysical research communications.
[9] G. Stewart,et al. Human Fusobacterium necrophorum strains have a leukotoxin gene and exhibit leukotoxic activity. , 2008, Journal of Medical Microbiology.
[10] A. Schmaier. Assembly, activation, and physiologic influence of the plasma kallikrein/kinin system. , 2008, International immunopharmacology.
[11] T. Riordan. Human Infection with Fusobacterium necrophorum (Necrobacillosis), with a Focus on Lemierre's Syndrome , 2007, Clinical Microbiology Reviews.
[12] J. Prag,et al. Detection of Fusobacterium necrophorum subsp. funduliforme in tonsillitis in young adults by real-time PCR. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[13] M. Malmsten,et al. The contact system—a novel branch of innate immunity generating antibacterial peptides , 2006, The EMBO journal.
[14] J. Brazier. Human infections with Fusobacterium necrophorum. , 2006, Anaerobe.
[15] A. Schmaier,et al. The Relative Priority of Prekallikrein and Factors XI/XIa Assembly on Cultured Endothelial Cells* , 2003, Journal of Biological Chemistry.
[16] H. Herwald,et al. The Conversion of Fibrinogen to Fibrin at the Surface of Curliated Escherichia coli Bacteria Leads to the Generation of Proinflammatory Fibrinopeptides* , 2003, Journal of Biological Chemistry.
[17] L. Björck,et al. Contact Activation by Pathogenic Bacteria: A Virulence Mechanism Contributing to the Pathophysiology of Sepsis , 2003, Scandinavian journal of infectious diseases.
[18] L. Björck,et al. Staphylococcus aureus Induces Release of Bradykinin in Human Plasma , 2001, Infection and Immunity.
[19] L. Björck,et al. Severe Lung Lesions Caused by Salmonella Are Prevented by Inhibition of the Contact System , 2000, The Journal of experimental medicine.
[20] L. Björck,et al. Protein GRAB of Streptococcus pyogenes Regulates Proteolysis at the Bacterial Surface by Binding α2-Macroglobulin* , 1999, The Journal of Biological Chemistry.
[21] L. Björck,et al. Activation of the contact-phase system on bacterial surfaces—a clue to serious complications in infectious diseases , 1998, Nature Medicine.
[22] A. Schmaier,et al. High molecular weight kininogen regulates prekallikrein assembly and activation on endothelial cells: a novel mechanism for contact activation. , 1998, Blood.
[23] A. Schmaier,et al. Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes. , 1997, Blood.
[24] T. Renné,et al. Absorption of kininogen from human plasma by Streptococcus pyogenes is followed by the release of bradykinin. , 1997, The Biochemical journal.
[25] L. Björck,et al. Assembly of human contact phase proteins and release of bradykinin at the surface of curli‐expressing Escherichia coli , 1996, Molecular microbiology.
[26] A. Schmaier,et al. Mapping the Cell Binding Site on High Molecular Weight Kininogen Domain 5 (*) , 1995, The Journal of Biological Chemistry.
[27] A. Schmaier,et al. Identification of an endothelial cell binding site on kininogen domain D3. , 1995, The Journal of biological chemistry.
[28] A. Schmaier,et al. The carboxyl terminus of bradykinin and amino terminus of the light chain of kininogens comprise an endothelial cell binding domain. , 1994, The Journal of biological chemistry.
[29] R. Colman,et al. Cleavage of human high molecular weight kininogen by factor XIa in vitro. Effect on structure and function. , 1985, The Journal of biological chemistry.
[30] Lauerman Lh,et al. Correlations between leukocidin production and virulence of two isolates of Fusobacterium necrophorum. , 1979, American journal of veterinary research.
[31] E. Shaw,et al. Synthesis of peptides of arginine chloromethyl ketone. Selective inactivation of human plasma kallikrein. , 1978, Biochemistry.
[32] J. Karkowska-Kuleta,et al. Binding and activation of the human plasma kinin-forming system on the cell walls of Candida albicans and Candida tropicalis , 2010, Biological chemistry.
[33] L. Björck,et al. Human kininogens interact with M protein, a bacterial surface protein and virulence determinant. , 1995, The Biochemical journal.
[34] A. Barrett,et al. [21] Human kininogens , 1988 .
[35] A. Barrett,et al. Human kininogens. , 1988, Methods in enzymology.